EODData

MEMBERSHIP REGISTER LOG IN

NYSE, EBS:

29 Aug 2025
LAST:

8.300

CHANGE:
 0.09		OPEN:
8.360		HIGH:
8.400		ASK:
25.740		VOLUME:
898.7K
CHG(%):
1.07		PREV:
8.390		LOW:
8.162		BID:
17.960		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
29 Aug 258.3608.4008.1628.300898.7K
28 Aug 258.5908.6998.3408.3901.23M
27 Aug 258.7808.8958.5658.590662.2K
26 Aug 259.1809.2208.5408.7101.22M
25 Aug 259.2109.2678.9809.2001.07M
22 Aug 259.4509.6609.2259.2301.24M
21 Aug 259.1509.3509.1309.320819.3K
20 Aug 259.1609.3408.9109.2501.04M
19 Aug 259.0509.4309.0509.190933K
18 Aug 258.8009.3808.8009.0701.28M

COMPANY PROFILE

Name:
About:Emergent BioSolutions Inc., a life sciences company, provides preparedness and response solutions for accidental, deliberate, and naturally occurring public health threats in the United States. The company offers NARCAN Nasal Spray for the emergency treatment of known or suspected opioid overdose; Vaxchora vaccine for the prevention of cholera; Vivotif vaccine for oral administration for the prevention of typhoid fever; Anthrasil for the treatment of inhalational anthrax; BioThrax, an anthrax vaccine; CYFENDUS for post-exposure prophylaxis of disease following suspected or confirmed exposure to Bacillus anthracis; and Raxibacumab injection for the treatment and prophylaxis of inhalational anthrax. It provides ACAM2000, a smallpox vaccine; CNJ-016 to address complications from smallpox vaccination; TEMBEXA for the treatment of smallpox disease caused by variola virus in adult and pediatric patients; Botulism Antitoxin Heptavalent for the treatment of symptomatic botulism; Ebanga for the treatment of Ebola; Trobigard, an atropine sulfate obidoxime chloride auto-injector. In addition, the company is developing EBS-LASV to prevent Lassa fever; EBS-MARV to prevent Marburg virus disease; EBS-SUDV to prevent Sudan virus disease; Pan-Ebola mAbs for the treatment of ebola virus; and WEVEE-VLP for equine encephalitis virus infections. Further, it provides contract development and manufacturing services comprising drug substance and product manufacturing, and packaging, as well as technology transfer, process, and analytical development services. The company was incorporated in 1998 and is headquartered in Gaithersburg, Maryland.
Sector:Healthcare
Address:300 Professional Drive, Gaithersburg, MD, United States, 20879
Website:https://www.emergentbiosolutions.com
CUSIP:29089Q105
CIK:0001367644
ISIN:US29089Q1058
FIGI:BBG000GW06J7
LEI:549300YW6TUOX8BE5103

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

P/E Ratio:3.52
PtB:0.92
PtS:0.58
EBITDA:216.8M
Shares:53.35M
Market Cap:442.81M

TECHNICAL INDICATORS

MA5:8.64
MA10:8.93
MA20:8.38
MA50:7.45
MA100:6.61
MA200:7.43
RSI14:52.89
WPR14:-100.00
MTM14:-0.61
ROC14:-0.07
ATR:0.43
Week High:9.66
Week Low:8.16
Month High:9.66
Month Low:5.62
Year High:12.73
Year Low:4.02
Volatility:39.89

RECENT DIVIDENDS

Date Amount
01 Aug 2016$1.86